BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19471239)

  • 1. Medical therapy of adrenocortical tumors.
    Kletter GB
    Minerva Endocrinol; 2009 Jun; 34(2):149-59. PubMed ID: 19471239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant mitotane therapy of adrenal cancer - use and controversy.
    Schteingart DE
    N Engl J Med; 2007 Jun; 356(23):2415-8. PubMed ID: 17554125
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant mitotane in adrenocortical carcinoma.
    Bertherat J; Coste J; Bertagna X
    N Engl J Med; 2007 Sep; 357(12):1256-7; author reply 1259. PubMed ID: 17881760
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant mitotane in adrenocortical carcinoma.
    Lee JE
    N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report.
    Hovi L; Wikström S; Vettenranta K; Heikkilä P; Saarinen-Pihkala UM
    Med Pediatr Oncol; 2003 May; 40(5):324-6. PubMed ID: 12652623
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
    Berruti A; Fassnacht M; Baudin E; Hammer G; Haak H; Leboulleux S; Skogseid B; Allolio B; Terzolo M
    J Clin Oncol; 2010 Aug; 28(23):e401-2; author reply e403. PubMed ID: 20567001
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: a case report.
    Beom SH; Lee KW; Yang Y; Choi Y; Song KH; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
    Jpn J Clin Oncol; 2011 Nov; 41(11):1287-91. PubMed ID: 21980052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored hormonal therapy in secretory adrenocortical cancer.
    Carmona-Bayonas A; Soler IO; Gómez FI; Billalabeitia EG; Saura HP; Tafalla MS; Díaz MP
    Ann Oncol; 2007 Jul; 18(7):1281. PubMed ID: 17675396
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant mitotane in adrenocortical carcinoma.
    Machens A; Dralle H
    N Engl J Med; 2007 Sep; 357(12):1258-9; author reply 1259. PubMed ID: 17891837
    [No Abstract]   [Full Text] [Related]  

  • 11. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in adrenocortical carcinoma.
    Fassnacht M; Kroiss M; Allolio B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
    Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
    Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies.
    Demeure MJ; Somberg LB
    Surg Oncol Clin N Am; 1998 Oct; 7(4):791-805. PubMed ID: 9735134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated primary hyperaldosteronism caused by adrenocortical carcinoma].
    Parajó A; Fírvida JL; Otero E; García M; Montero M
    Arch Esp Urol; 2000 Dec; 53(10):931-4. PubMed ID: 11213398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The next generation of therapies for adrenocortical cancers.
    Kirschner LS
    Trends Endocrinol Metab; 2012 Jul; 23(7):343-50. PubMed ID: 22626690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of adrenal cortical carcinoma].
    Oida T; Souma T; Doi H; Hida S; Takasu K
    Hinyokika Kiyo; 2002 Nov; 48(11):667-70. PubMed ID: 12512139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
    Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
    J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.